Frontiers | Adhesion Molecules in Multiple Myeloma Oncogenesis and Targeted Therapy

Adhesion Molecules in Multiple Myeloma Oncogenesis and Targeted Therapy

1,561
Total downloads
5,732
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 13 Sep 2021

Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and β-Catenin Nuclear Enrichment

Zhenqing Xie
Yan Xu
Xiaojing Wei
Gang An
Mu Hao
Zhen Yu
Lugui Qiu

Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and β-Catenin Nuclear Enrichment

doi 10.3389/fonc.2021.729799

1,818 views
3 citations

ORIGINAL RESEARCH

Published on 03 Jun 2021

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling

Huan Liu
Zhiming Wang
Jin He
Zongwei Li
Jerry Y. Gao
Rui Liu
Pei Lin
Jing Yang

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling

doi 10.3389/fonc.2021.692190

1,730 views
1 citation

Share on

Frontiers in Oncology

Frontiers in Oncology

Hematologic Malignancies

Impact

5,732Topic views
2,857Article views
1,561Article downloads